We are focused on drug discovery at unprecedented speed and scale, with lower risk and higher certainty across multiple diseases in parallel.
With data from hundreds of millions of experiments, we have mapped the effects of thousands of compounds on gene expression to discover new therapies. Our Drug-Gene Atlas maps molecular structure and drug action to the whole cell transcriptome, revealing therapeutic candidates that rebalance gene expression to treat disease. Our proprietary artificial intelligence modeling suite, Conductor AI, used our Drug-Gene Atlas to discover and predict the effects of new drugs at transcriptome scale.
Company Details
- Employees
- 23
- Founded
- -
- Address
- Palo Alto, California, Us
- Industry
- Biotechnology
- Website
- https://www.transcriptabio.com/
- Keywords
- drug discovery and transcriptome.
- HQ
- Palo Alto, California
Transcripta Bio Questions
Transcripta Bio's website is https://www.transcriptabio.com/
Transcripta Bio's LinkedIn profile is https://www.linkedin.com/company/transcriptabio
Transcripta Bio has
23 employees.
View email and phone details for 23
employees at Transcripta Bio.
Transcripta Bio's industry is
Biotechnology
Transcripta Bio's top competitors are
Aikium Inc.,
Metasight Diagnostics,
Nebius,
Serna Bio,
Science Exchange,
Allstripes (Now Picnichealth),
Jazz Venture Partners,
Converge Bio,
Ataraxis Ai,
Infinimmune.
Transcripta Bio's categories are Biotechnology
Transcripta Bio's founding year is 2020
